Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board
September 01, 2015 at 16:14 PM EDT
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of ...